Related Experiment Video
Updated: May 12, 2026

10:16
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Autoantibodies in the grocery shop: does quantity matter?
1Central Diagnostic Laboratory, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands. jan.damoiseaux@mumc.nl
Immunologic Research
|April 11, 2013
Summary
Quantifying autoantibodies aids in diagnosing autoimmune diseases and monitoring treatment effectiveness. While higher autoantibody levels correlate with disease presence, their rise doesn't always predict relapse.
Area of Science:
- Immunology
- Clinical Diagnostics
- Autoimmune Diseases
Background:
- Autoantibody testing is crucial for diagnosing autoimmune conditions.
- Detection of autoantibodies is incorporated into classification criteria and diagnostic guidelines.
- The clinical utility of autoantibody quantification requires further investigation.
Purpose of the Study:
- To evaluate the clinical usefulness of autoantibody quantification in diagnosing and monitoring autoimmune diseases.
- To assess the role of quantitative autoantibody measurements during patient follow-up.
- To determine if autoantibody levels correlate with disease activity and relapses.
Main Methods:
- Review of existing literature on autoantibody quantification in autoimmune diseases.
- Analysis of studies examining the diagnostic and prognostic value of autoantibody levels.
- Evaluation of the impact of quantitative autoantibody results on clinical decision-making.
Main Results:
- Sufficient evidence indicates that higher autoantibody levels increase the likelihood of a specific autoimmune disease.
- Quantitative autoantibody measurements can be valuable for monitoring therapeutic efficacy, depending on the treatment used.
- The correlation between increased autoantibody levels and subsequent disease relapses is not absolute.
Conclusions:
- Autoantibody quantification offers clinical utility in both diagnosis and monitoring of autoimmune diseases.
- Quantitative reporting of autoantibody levels with clinical interpretation is essential for healthcare providers.
- Further research may refine the role of autoantibody quantification in predicting disease relapses.

